Junshu Zhao
Senior Director, Cmc Leadership and Business Development @Bristol Myers Squibb
Signup · Get unlimited contacts
WORK HISTORY
Senior Director, Cmc Leadership and Business Development @Bristol Myers Squibb
NJ, US
Lead CMC due diligence for global business development opportunities, including in-licensing, collaborations, and M&A. Partner with R&D, manufacturing, quality, regulatory, finance, and corporate strategy teams to- Evaluate CMC risks, value drivers, and integration requirements across small molecules, biologics, and novel modalities- Design development pathways and manufacturing network strategies that enable seamless onboarding of external assets into the BMS pipeline- Conduct cost analyses and scenario planning to inform deal valuation and negotiations- Translate technical findings into strategic recommendations that influence deal structure, timelines, and resource allocation- Engage in cross-border, cross-functional collaborations, ensuring technical and operational readiness for asset integration.This role integrates scientific, manufacturing, and business expertise to strengthen BMS’s development portfolio, accelerate innovation delivery, and optimize return on investment for partnered assets.
EDUCATION
Columbia Business School
MBA, Executive Cohort, Business Administration and Management, General
University of Science and Technology of China
BS, Chemical Physics
University of Wisconsin-Madison
PhD, Chemistry
SKILLS
ABOUT JUNSHU ZHAO
I am a senior pharmaceutical leader specializing in connecting external innovation with internal capabilities to strengthen global drug development pipelines. As Senior Director of GPS Business Development and CMC Strategy at Bristol Myers Squibb, I lead technical due diligence for collaborations, in-licensing, and M&A—evaluating CMC risks, uncovering value drivers, and designing integration strategies that enable seamless onboarding of assets into development. My role bridges science, manufacturing, and corporate strategy to ensure each partnership advances both patient outcomes and business growth.With 15 years of industry experience, I have built a proven record in CMC leadership, guiding programs from preclinical stages to commercialization across small molecules, biologics, and antibody-drug conjugates (ADCs). I led the CMC development strategy for the most advanced ADC in the BMS portfolio, designing manufacturing networks, managing process changes, and presenting industry perspectives at health authority conferences to promote collaborative, risk-based acceleration. I am recognized for advancing innovation platforms, including earning the prestigious R&D James Palmer Award for developing mini-tablets as a pediatric formulation platform—simplifying development, cutting costs, and improving access for patients. My approach combines deep scientific expertise with strategic vision, ensuring that every technical decision supports the broader business objectives.Beyond my core responsibilities, I champion inclusion, cultural fluency, and global collaboration as a leader in the Pan Asian Network People & Business Resource Group. I launched the Geographical Expansion Podcast to foster cultural fluency and market insight across BMS’s global footprint.I hold a Ph.D. in Physical Chemistry from the University of Wisconsin–Madison and an MBA from Columbia Business School (Dean’s Honors with Distinction, top 5%). My passion is building high-impact partnerships and technical strategies that translate cutting-edge science into transformative, commercially successful medicines.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.